Compare iShares China Large-Cap ETF (FXI) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? iShares China Large-Cap ETF trades at $33.93 (market cap $3.90B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 16.4× iShares China Large-Cap ETF's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.47% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals.
| FXI | RELX | |
|---|---|---|
Market Cap | $3.90B | $63.89B |
Volume | 21,620,520 | 2,760,502 |
52-Week High | $41.08 | $46.80 |
52-Week Low | $31.59 | $27.73 |
Typical Hold Time | 151 Days | — |
Sector | — | Industrials |
Enterprise Value | — | $75.40B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI trades at $34.17 with minimal daily movement (+0.09%). The technical picture is bearish with moving averages signaling caution, though oscillators are neutral. Recent news highlights China's economic challenges including industrial overcapacity and weak domestic consumption, while corporate profits surged 26% in Q2 2026. The ETF trades at a significant discount to U.S. equities with a P/E of 11.10 versus the S&P 500's 22.54, offering potential value amid high political risk.
FXI presents a contrarian opportunity for investors seeking China exposure at discounted valuations, but faces substantial headwinds from U.S.-China tensions and domestic economic rebalancing. The ETF's heavy financial sector weighting and state-backed monetary support provide stability, though momentum remains weak. Key risks include escalating trade protectionism and China's export control uncertainties.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
